Copyright Reports & Markets. All rights reserved.

Global Stem Cell Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Stem Cell Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Autologous
      • 1.4.3 Allogeneic
    • 1.5 Market by Application
      • 1.5.1 Global Stem Cell Therapy Market Share by Application (2014-2025)
      • 1.5.2 Musculoskeletal Disorder
      • 1.5.3 Wounds & Injuries
      • 1.5.4 Cornea
      • 1.5.5 Cardiovascular Diseases
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Stem Cell Therapy Market Size
    • 2.2 Stem Cell Therapy Growth Trends by Regions
      • 2.2.1 Stem Cell Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Stem Cell Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Stem Cell Therapy Market Size by Manufacturers
      • 3.1.1 Global Stem Cell Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Stem Cell Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Stem Cell Therapy Key Players Head office and Area Served
    • 3.3 Key Players Stem Cell Therapy Product/Solution/Service
    • 3.4 Date of Enter into Stem Cell Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Stem Cell Therapy Market Size by Type (2014-2019)
    • 4.2 Global Stem Cell Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Stem Cell Therapy Market Size (2014-2019)
    • 5.2 Stem Cell Therapy Key Players in United States
    • 5.3 United States Stem Cell Therapy Market Size by Type
    • 5.4 United States Stem Cell Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Stem Cell Therapy Market Size (2014-2019)
    • 6.2 Stem Cell Therapy Key Players in Europe
    • 6.3 Europe Stem Cell Therapy Market Size by Type
    • 6.4 Europe Stem Cell Therapy Market Size by Application

    7 China

    • 7.1 China Stem Cell Therapy Market Size (2014-2019)
    • 7.2 Stem Cell Therapy Key Players in China
    • 7.3 China Stem Cell Therapy Market Size by Type
    • 7.4 China Stem Cell Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Stem Cell Therapy Market Size (2014-2019)
    • 8.2 Stem Cell Therapy Key Players in Japan
    • 8.3 Japan Stem Cell Therapy Market Size by Type
    • 8.4 Japan Stem Cell Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Stem Cell Therapy Market Size (2014-2019)
    • 9.2 Stem Cell Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Stem Cell Therapy Market Size by Type
    • 9.4 Southeast Asia Stem Cell Therapy Market Size by Application

    10 India

    • 10.1 India Stem Cell Therapy Market Size (2014-2019)
    • 10.2 Stem Cell Therapy Key Players in India
    • 10.3 India Stem Cell Therapy Market Size by Type
    • 10.4 India Stem Cell Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Stem Cell Therapy Market Size (2014-2019)
    • 11.2 Stem Cell Therapy Key Players in Central & South America
    • 11.3 Central & South America Stem Cell Therapy Market Size by Type
    • 11.4 Central & South America Stem Cell Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Osiris Therapeutics
      • 12.1.1 Osiris Therapeutics Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Stem Cell Therapy Introduction
      • 12.1.4 Osiris Therapeutics Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.1.5 Osiris Therapeutics Recent Development
    • 12.2 NuVasive
      • 12.2.1 NuVasive Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Stem Cell Therapy Introduction
      • 12.2.4 NuVasive Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.2.5 NuVasive Recent Development
    • 12.3 Chiesi Pharmaceuticals
      • 12.3.1 Chiesi Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Stem Cell Therapy Introduction
      • 12.3.4 Chiesi Pharmaceuticals Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.3.5 Chiesi Pharmaceuticals Recent Development
    • 12.4 JCR Pharmaceutical
      • 12.4.1 JCR Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Stem Cell Therapy Introduction
      • 12.4.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.4.5 JCR Pharmaceutical Recent Development
    • 12.5 Pharmicell
      • 12.5.1 Pharmicell Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Stem Cell Therapy Introduction
      • 12.5.4 Pharmicell Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.5.5 Pharmicell Recent Development
    • 12.6 Medi-post
      • 12.6.1 Medi-post Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Stem Cell Therapy Introduction
      • 12.6.4 Medi-post Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.6.5 Medi-post Recent Development
    • 12.7 Anterogen
      • 12.7.1 Anterogen Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Stem Cell Therapy Introduction
      • 12.7.4 Anterogen Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.7.5 Anterogen Recent Development
    • 12.8 Molmed
      • 12.8.1 Molmed Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Stem Cell Therapy Introduction
      • 12.8.4 Molmed Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.8.5 Molmed Recent Development
    • 12.9 Takeda (TiGenix)
      • 12.9.1 Takeda (TiGenix) Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Stem Cell Therapy Introduction
      • 12.9.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2014-2019)
      • 12.9.5 Takeda (TiGenix) Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
      In the last several years, global stem cell therapy market developed fast at a average growth rate of 46.81%. In 2017, the global stem cell therapy market size was 235 million USD, and the market is expected to be 277 million USD.
      On the basis of therapeutic application, the global stem cell therapy market is segmented into Musculoskeletal Disorder, Wounds & Injuries, Cornea, Cardiovascular Diseases, and other applications. The musculoskeletal disorders and Wounds & Injuries are expected to dominated the market.
      In 2018, the global Stem Cell Therapy market size was 280 million US$ and it is expected to reach 980 million US$ by the end of 2025, with a CAGR of 19.7% during 2019-2025.

      This report focuses on the global Stem Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell Therapy development in United States, Europe and China.

      The key players covered in this study
      Osiris Therapeutics
      NuVasive
      Chiesi Pharmaceuticals
      JCR Pharmaceutical
      Pharmicell
      Medi-post
      Anterogen
      Molmed
      Takeda (TiGenix)

      Market segment by Type, the product can be split into
      Autologous
      Allogeneic

      Market segment by Application, split into
      Musculoskeletal Disorder
      Wounds & Injuries
      Cornea
      Cardiovascular Diseases
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Stem Cell Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Stem Cell Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Stem Cell Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now